Your gut bacteria might hold the key to lung cancer treatment
NCT ID NCT07752589
First seen Aug 07, 2026 · Last updated Aug 07, 2026
Summary
This study is exploring whether the bacteria in your gut can predict how well a certain type of lung cancer responds to treatment. Researchers are following 100 people with stage II-IIIB non-small cell lung cancer who are receiving chemoimmunotherapy before surgery. The goal is to see if the makeup of gut microbes is linked to how much the tumor shrinks or disappears, which could lead to more personalized treatment plans.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Neoadjuvant chemoimmunotherapy (PD-1 inhibitor plus platinum-based chemotherapy)
- What this could lead to
- If gut bacteria predict treatment response, doctors might tailor lung cancer therapy based on a patient's microbiome, potentially improving outcomes.
- What could go wrong
- This is an observational study, so it won't prove cause and effect. The link between gut bacteria and treatment response may not be strong enough to guide clinical decisions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GUT MICROBIOMES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, 510060, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Immunotherapy's hidden toll on daily life be measured?
- New radiation approach aims to boost lung cancer treatment in poor responders
- AI could predict who lives longer after lung cancer immunotherapy
- Triple threat: radiation plus Immuno-Chemo shows promise for lung cancer
- Milk powder may reshape gut bacteria in middle age, study hints
- Could a heart drug boost colon cancer treatment?